Cargando…
Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes
OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, t...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518500/ https://www.ncbi.nlm.nih.gov/pubmed/18544706 http://dx.doi.org/10.2337/db08-0332 |
_version_ | 1782158578830802944 |
---|---|
author | Mäkinen, Ville-Petteri Forsblom, Carol Thorn, Lena M. Wadén, Johan Gordin, Daniel Heikkilä, Outi Hietala, Kustaa Kyllönen, Laura Kytö, Janne Rosengård-Bärlund, Milla Saraheimo, Markku Tolonen, Nina Parkkonen, Maija Kaski, Kimmo Ala-Korpela, Mika Groop, Per-Henrik |
author_facet | Mäkinen, Ville-Petteri Forsblom, Carol Thorn, Lena M. Wadén, Johan Gordin, Daniel Heikkilä, Outi Hietala, Kustaa Kyllönen, Laura Kytö, Janne Rosengård-Bärlund, Milla Saraheimo, Markku Tolonen, Nina Parkkonen, Maija Kaski, Kimmo Ala-Korpela, Mika Groop, Per-Henrik |
author_sort | Mäkinen, Ville-Petteri |
collection | PubMed |
description | OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. RESEARCH DESIGN AND METHODS—At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). RESULTS—The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3–13.1) for men and 10.7-fold (7.9–13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration. CONCLUSIONS—The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality. |
format | Text |
id | pubmed-2518500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-25185002009-09-01 Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes Mäkinen, Ville-Petteri Forsblom, Carol Thorn, Lena M. Wadén, Johan Gordin, Daniel Heikkilä, Outi Hietala, Kustaa Kyllönen, Laura Kytö, Janne Rosengård-Bärlund, Milla Saraheimo, Markku Tolonen, Nina Parkkonen, Maija Kaski, Kimmo Ala-Korpela, Mika Groop, Per-Henrik Diabetes Complications OBJECTIVE—Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset. RESEARCH DESIGN AND METHODS—At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths). RESULTS—The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3–13.1) for men and 10.7-fold (7.9–13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration. CONCLUSIONS—The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality. American Diabetes Association 2008-09 /pmc/articles/PMC2518500/ /pubmed/18544706 http://dx.doi.org/10.2337/db08-0332 Text en Copyright © 2008, American Diabetes Association https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Complications Mäkinen, Ville-Petteri Forsblom, Carol Thorn, Lena M. Wadén, Johan Gordin, Daniel Heikkilä, Outi Hietala, Kustaa Kyllönen, Laura Kytö, Janne Rosengård-Bärlund, Milla Saraheimo, Markku Tolonen, Nina Parkkonen, Maija Kaski, Kimmo Ala-Korpela, Mika Groop, Per-Henrik Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title | Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title_full | Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title_fullStr | Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title_full_unstemmed | Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title_short | Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes |
title_sort | metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes |
topic | Complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518500/ https://www.ncbi.nlm.nih.gov/pubmed/18544706 http://dx.doi.org/10.2337/db08-0332 |
work_keys_str_mv | AT makinenvillepetteri metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT forsblomcarol metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT thornlenam metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT wadenjohan metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT gordindaniel metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT heikkilaouti metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT hietalakustaa metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT kyllonenlaura metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT kytojanne metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT rosengardbarlundmilla metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT saraheimomarkku metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT tolonennina metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT parkkonenmaija metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT kaskikimmo metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT alakorpelamika metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT groopperhenrik metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes AT metabolicphenotypesvascularcomplicationsandprematuredeathsinapopulationof4197patientswithtype1diabetes |